These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35901905)

  • 1. Recent advances in metabolism and toxicity of tyrosine kinase inhibitors.
    Zhao Q; Wu ZE; Li B; Li F
    Pharmacol Ther; 2022 Sep; 237():108256. PubMed ID: 35901905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinase Inhibitors FDA Approved 2018-2023: Drug Targets, Metabolic Pathways, and Drug-Induced Toxicities.
    Latham BD; Geffert RM; Jackson KD
    Drug Metab Dispos; 2024 May; 52(6):479-492. PubMed ID: 38286637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma.
    Miller JA; Balagamwala EH; Angelov L; Suh JH; Rini B; Garcia JA; Ahluwalia M; Chao ST
    J Neurosurg Spine; 2016 Dec; 25(6):766-774. PubMed ID: 27391397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABC transporters in multi-drug resistance and ADME-Tox of small molecule tyrosine kinase inhibitors.
    Deng J; Shao J; Markowitz JS; An G
    Pharm Res; 2014 Sep; 31(9):2237-55. PubMed ID: 24842659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic activation of tyrosine kinase inhibitors: recent advance and further clinical practice.
    Yan M; Li W; Li WB; Huang Q; Li J; Cai HL; Gong H; Zhang BK; Wang YK
    Drug Metab Rev; 2023; 55(1-2):94-106. PubMed ID: 36453523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic mice and metabolomics for study of hepatic xenobiotic metabolism and toxicity.
    Gonzalez FJ; Fang ZZ; Ma X
    Expert Opin Drug Metab Toxicol; 2015 Jun; 11(6):869-81. PubMed ID: 25836352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating network pharmacology and drug side-effect data to explore mechanism of liver injury-induced by tyrosine kinase inhibitors.
    Tang M; Wu ZE; Li F
    Comput Biol Med; 2024 Mar; 170():108040. PubMed ID: 38308871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardiotoxicity and myocyte damage caused by small molecule anticancer tyrosine kinase inhibitors is correlated with lack of target specificity.
    Hasinoff BB
    Toxicol Appl Pharmacol; 2010 Apr; 244(2):190-5. PubMed ID: 20045709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS-based Metabolomics of Xenobiotic-induced Toxicities.
    Chen C; Kim S
    Comput Struct Biotechnol J; 2013; 4():e201301008. PubMed ID: 24688689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?
    Brózik A; Hegedüs C; Erdei Z; Hegedus T; Özvegy-Laczka C; Szakács G; Sarkadi B
    Expert Opin Drug Metab Toxicol; 2011 May; 7(5):623-42. PubMed ID: 21410427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ponatinib-induced cardiotoxicity: delineating the signalling mechanisms and potential rescue strategies.
    Singh AP; Glennon MS; Umbarkar P; Gupte M; Galindo CL; Zhang Q; Force T; Becker JR; Lal H
    Cardiovasc Res; 2019 Apr; 115(5):966-977. PubMed ID: 30629146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrimination of hand-foot skin reaction caused by tyrosine kinase inhibitors based on direct keratinocyte toxicity and vascular endothelial growth factor receptor-2 inhibition.
    Hasan Alshammari A; Masuo Y; Fujita KI; Shimada K; Iida N; Wakayama T; Kato Y
    Biochem Pharmacol; 2022 Mar; 197():114914. PubMed ID: 35041812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro assessment of the photo(geno)toxicity associated with Lapatinib, a Tyrosine Kinase inhibitor.
    García-Lainez G; Vayá I; Marín MP; Miranda MA; Andreu I
    Arch Toxicol; 2021 Jan; 95(1):169-178. PubMed ID: 32815004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of CML TKI Induced Cardiovascular Toxicity and Development of Potential Rescue Strategies in a Zebrafish Model.
    Cheng S; Jin P; Li H; Pei D; Shu X
    Front Pharmacol; 2021; 12():740529. PubMed ID: 34733159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Exploring Tyrosine Kinase Inhibitor (TKI)-Induced Nephrotoxicity: An Emerging Issue from Bench to Bedside].
    Collotta D; Aimaretti E; Collino M
    G Ital Nefrol; 2023 Oct; 40(Suppl 81):. PubMed ID: 38007828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatotoxicity of tyrosine kinase inhibitors: clinical and regulatory perspectives.
    Shah RR; Morganroth J; Shah DR
    Drug Saf; 2013 Jul; 36(7):491-503. PubMed ID: 23620168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicities of Receptor Tyrosine Kinase Inhibitors in Cancer Pharmacotherapy: Management with Clinical Pharmacology.
    Fujita KI; Ishida H; Kubota Y; Sasaki Y
    Curr Drug Metab; 2017; 18(3):186-198. PubMed ID: 28059038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TKI combination therapy: strategy to enhance dasatinib uptake by inhibiting Pgp- and BCRP-mediated efflux.
    D'Cunha R; Bae S; Murry DJ; An G
    Biopharm Drug Dispos; 2016 Oct; 37(7):397-408. PubMed ID: 27418107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Review on Selected Xenobiotics and Their Impacts on Gut Microbiome and Metabolome.
    Jin Y; Chi J; LoMonaco K; Boon A; Gu H
    Trends Analyt Chem; 2023 Sep; 166():. PubMed ID: 37484879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors.
    Chen YM; Lai CH; Rau KM; Huang CH; Chang HC; Chao TY; Tseng CC; Fang WF; Chung YH; Wang YH; Su MC; Huang KT; Liu SF; Chen HC; Chang YC; Chang YP; Wang CC; Lin MC
    BMC Cancer; 2016 Nov; 16(1):868. PubMed ID: 27821111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.